The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response

Cancers
María Cámara-QuílezMaría-Esperanza Cerdán

Abstract

High mobility group box B (HMGB) proteins are overexpressed in different types of cancers such as epithelial ovarian cancers (EOC). We have determined the first interactome of HMGB1 and HMGB2 in epithelial ovarian cancer (the EOC-HMGB interactome). Libraries from the SKOV-3 cell line and a primary transitional cell carcinoma (TCC) ovarian tumor were tested by the Yeast Two Hybrid (Y2H) approach. The interactome reveals proteins that are related to cancer hallmarks and their expression is altered in EOC. Moreover, some of these proteins have been associated to survival and prognosis of patients. The interaction of MIEN1 and NOP53 with HMGB2 has been validated by co-immunoprecipitation in SKOV-3 and PEO1 cell lines. SKOV-3 cells were treated with different anti-tumoral drugs to evaluate changes in HMGB1, HMGB2, MIEN1 and NOP53 gene expression. Results show that combined treatment of paclitaxel and carboplatin induces a stronger down-regulation of these genes in comparison to individual treatments. Individual treatment with paclitaxel or olaparib up-regulates NOP53, which is expressed at lower levels in EOC than in non-cancerous cells. On the other hand, bevacizumab diminishes the expression of HMGB2 and NOP53. This study also sho...Continue Reading

References

Jan 1, 1993·Cancer Chemotherapy and Pharmacology·N M LopesB K Bhuyan
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jul 17, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P A BrennanD Górecki
May 17, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Viktor Brabec, Jana Kasparkova
Jun 18, 2005·Biochemical and Biophysical Research Communications·Napoleone FerraraWilliam Novotny
Sep 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ie-Ming ShihTian-Li Wang
Apr 29, 2008·Biochemical and Biophysical Research Communications·S C AshD E Britt
Jan 10, 2009·International Journal of Cancer. Journal International Du Cancer·Katharine L SodekTheodore J Brown
Oct 9, 2009·Immunological Investigations·Sarah KimAngela DeMichele
Feb 4, 2010·Biochimica Et Biophysica Acta·Tetsuya Ueda, Michiteru Yoshida
Apr 20, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Brad A BryanPatricia A D'Amore
May 12, 2010·The Journal of Clinical Investigation·Bart van de SluisEzra Burstein
Aug 7, 2010·Journal of Proteome Research·Silvia SchiareaChiara Chiabrando
Dec 7, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Daichi MaedaIe-Ming Shih
Jul 12, 2011·The American Journal of Pathology·Jee-Youn KimJae-Hoon Park
Aug 2, 2011·Nature Medicine·Masato SasakiAkira Suzuki
Mar 6, 2012·Biochemical and Biophysical Research Communications·Qingchang LiEnhua Wang
Jun 29, 2012·Oncology Letters·Satoshi IchigoAtsushi Imai
Aug 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sooncheol LeeShu-Bing Qian
Sep 29, 2012·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Rola H AliC Blake Gilks
Nov 3, 2012·Disease Models & Mechanisms·Dylan T JonesKairbaan M Hodivala-Dilke
Jan 3, 2013·International Journal of Cancer. Journal International Du Cancer·Eun Mi JeSug Hyung Lee
Jan 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Mira SastriSusan S Taylor
Feb 5, 2013·The Journal of Pathology·Jim Jinn-Chyuan SheuIe-Ming Shih
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
May 30, 2013·Nature Genetics·UNKNOWN GTEx Consortium
Jul 9, 2013·The Journal of Biological Chemistry·Huarui Lu, Timothy C Hallstrom
Jul 25, 2013·British Journal of Cancer·T H-Y LeungH Y-S Ngan
Oct 15, 2013·Cell Reports·Katherine E SloanNicholas J Watkins
Oct 23, 2013·Cancer Research·Yi-Yuan HuangZhiyuan Shen

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE54772

Methods Mentioned

BETA
two-hybrid
Y2H
co-immunoprecipitation
RNAseq
ubiquitination
nuclear translocation
Two Hybrid
scraping
immunoprecipitations
PCR

Key Resources (RRID) Mentioned

CVCL_5546

Software Mentioned

cBioportal
ECO Real - Time PCR System

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.